Prognostic index for patients with parotid carcinoma: International external validation in a belgian-German database

Cancer

Volumn 115, Issue 3, 2009, Pages 540-550

  Poorten, Vincent Vander ^a,b,c   Hart, Augustinus ^d   Vauterin, Tom ^a,b,c,h   Jeunen, Gert ^a,b,i   Schoenaers, Joseph ^a,b   Hamoir, Marc ^c,e   Balm, Alphonsus ^d   Stennert, Eberhard ^c,f   Guntinas Lichius, Orlando ^c,f,g   Delaere, Pierre ^a,b  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b Katholieke Universiteit   (Belgium)

^c European Salivary Gland Society   (Switzerland)

^d NETHERLANDS CANCER INSTITUTE   (Netherlands)

^e CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^f UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^g FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^h General Hospital St Jan   (Belgium)

ⁱ General Hospital Mariaziekenhuis Noord Limburg   (Belgium)

Author keywords

Parotid carcinoma; Prognostic factors; Prognostic index; Salivary gland neoplasm; Validation

Indexed keywords

ADULT; AGED; ARTICLE; CALCULATION; CANCER RECURRENCE; CANCER SURVIVAL; DATA BASE; DISEASE FREE SURVIVAL; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PAROTID GLAND CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE; VALIDATION PROCESS;

ADULT; AGED; BELGIUM; DATABASES AS TOPIC; DISEASE-FREE SURVIVAL; FEMALE; GERMANY; HUMANS; MALE; MIDDLE AGED; PAROTID NEOPLASMS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; STATISTICS AS TOPIC; SURVIVAL ANALYSIS;

EID: 60049084183     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.24015     Document Type: Article

References (32)

1. Vander Poorten VLM, Balm AJM, Hilgers FJM, et al. The development of a prognostic score for patients with parotid carcinoma. Cancer. 1999;85:2057-2067.
2. Vander Poorten VL, Hart AAA, van der Laan BF, et al. Prognostic index for patients with parotid carcinoma: external validation using the nationwide 1985-1994 Dutch Head and Neck Oncology Cooperative Group database. Cancer. 2003;97:1453-1463.
3. Altman DG, Royston P. What do we mean by validating a prognostic model? Stat Med.. 2000;19:453-473.
4. Justice AC, Covinsky KE, Berlin JA. Assessing the generalizability of prognostic information. Ann Intern Med. 1999;130:515-524.
5. Thackray AC, Sobin LH, eds. World Health Organization. International Histological Classification of Tumors, no. 7: Histological Typing of Salivary Gland Tumours. In: World Health Organization. Geneva, Switzerland: World Health Organization; 1972:16-26.
6. Seifert G, Sobin LH. The World Health Organization's histological classification of salivary gland tumors. A commentary on the second edition. Cancer. 1992;70:379-385.
7. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457-481.
8. Harrell FE Jr, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996;15:361-387.
9. Schoenfeld D. Partial residuals for the proportional hazards regression model. Biometrika. 1982;69:239-241.
10. Therneau TM, Grambsch PM, Fleming TR. Martingale- based residuals for survival models. Biometrika. 1990;77:147-160.
11. Klein JP. Small sample moments of the estimators of the variance of the Kaplan-Meier and Nelson-Aalen estimators. Scand J Stat. 1991;18:333-340.
12. van Houwelingen HC. Validation, calibration, revision and combination of prognostic survival models. Stat Med. 2000;19:3401-3415.
13. Parry J, Cummins C, Redman V, et al. Incidence and survival of malignant parotid tumours in the West Midlands region 1977-1986. Clin Oncol (R Coll Radiol). 1993;5:150-153.
14. Poulsen MG, Pratt GR, Kynaston B, Tripcony LB. Prognostic variables in malignant epithelial tumors of the parotid. Int J Radiat Oncol Biol Phys. 1992;23:327-332.
15. North CA, Lee DJ, Piantadosi S, Zahurak M, Johns ME. Carcinoma of the major salivary glands treated by surgery or surgery plus postoperative radiotherapy. Int J Radiat Oncol Biol Phys. 1990;18:1319-1326.
16. Witten J, Hybert F, Hansen HS. Treatment of malignant tumors in the parotid glands. Cancer. 1990;65:2515-2520.
17. Renehan AG, Gleave EN, Slevin NJ, McGurk M. Clinicopathological and treatment-related factors influencing survival in parotid cancer. Br J Cancer. 1999;80:1296-1300.
18. Spiro RH, Armstrong J, Harrison L, Geller NL, Lin SY, Strong EW. Carcinoma of major salivary glands. Recent trends. Arch Otolaryngol Head Neck Surg. 1989;115:316-321.
19. Mackillop WJ. The importance of prognosis in cancer medicine. In: Gospodarowicz MK, Henson DE, Hutter RVP, O'Sullivan B, Sobin LH, Wittekind C, eds. Prognostic Factors in Cancer. 2nd ed. New York, NY: Wiley-Liss; 2001:3-16.
20. Regis de Brito Santos I, Kowalski LP, Cavalcante de Araujo V, Flavia Logullo A, Magrin J. Multivariate analysis of risk factors for neck metastases in surgically treated parotid carcinomas. Arch Otolaryngol Head Neck Surg. 2001;127:56-60.
21. Spiro IJ, Wang CC, Montgomery WW. Carcinoma of the parotid gland. Analysis of treatment results and patterns of failure after combined surgery and radiation therapy. Cancer. 1993;71:2699-2705.
22. Magnano M, Gervasio CF, Cravero L, et al. Treatment of malignant neoplasms of the parotid gland. Otolaryngol Head Neck Surg. 1999;121:627-632.
23. Numata T, Muto H, Shiba K, Nagata H, Terada N, Konno A. Evaluation of the validity of the 1997 International Union Against Cancer TNM classification of major salivary gland carcinoma. Cancer. 2000;89:1664-1669.
24. Van Houwelingen JC, Le Cessie S. Predictive value of statistical models. Stat Med. 1990;9:1303-1325.
25. Charlson ME, Ales KL, Simon R, MacKenzie CR. Why predictive indexes perform less well in validation studies. Is it magic or methods? Arch Intern Med. 1987;147:2155-2161.
26. Dukes CE, Bussey HJR. The spread of rectal cancer and its effect on prognosis. Br J Cancer. 1958;12:309-320.
27. Jass JR, Love SB, Northover JMA. A new prognostic classification of rectal cancer. Lancet. 1987;1:1303-1306.
28. Harrison JC, Dean PJ, el Zeky F, Vander Zwaag R. From Dukes through Jass: pathological prognostic indicators in rectal cancer. Hum Pathol. 1994;25:498-505.
29. Simon R, Altman DG. Statistical aspects of prognostic factor studies in oncology. Br J Cancer. 1994;69:979-985.
30. Windeler J. Prognosis-what does the clinician associate with this notion? Stat Med. 2000;19:425-430.
31. Harmanek P, Sobin LH, eds. Salivary Glands. In: International Union Against Cancer. UICC TNM Atlas: Illustrated Guide to the TNM/pTNM Classification of Malignant Tumours. 3rd ed, 2nd revision. Berlin, Germany: Springer-Verlag; 1992:50-55.
32. Seifert G, Brocheriou C, Cardesa A, Eveson JW. WHO International Histological Classification of Tumours. Tentative histological classification of salivary gland tumours. Pathol Res Pract. 1990;186:555-581.